Loading...

Propidium Iodide Solution

Pricing & Availability
Regulatory Status
RUO
Other Names
PI
Ave. Rating
Submit a Review
Product Citations
publications
See Propidium Iodide spectral data
Cat # Size Price Save
421301 2 mL ¥11,880
Description

Propidium iodide (PI) is a fluorescent dye that binds to DNA. When excited by 488nm laser light, it can be detected with in the PE/Texas Red® channel with a bandpass filter 610/10. It is commonly used in evaluation of cell viability or DNA content in cell cycle analysis by flow cytometry.

Product Details
Technical data sheet

Product Details

Formulation
Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide.
Concentration
0.5 mg/ml
Storage & Handling
The solution should be stored undiluted between 2°C and 8°C, and protect from light. Caution: This solution contains hazardous material; handle with care.
Application

FC - Quality tested
Recommended Usage

The suggested use of this solution for viability staining is 10 µl per million cells in 0.5 ml/test, and incubate for 15 minutes at 4 °C before analysis. For Cell Cycle analysis, please see our Propidium Iodide Cell Cycle Staining Protocol. Caution: This solution is toxigenic and mutagenic; handle with care.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Propidium Iodide Solution can be used in evaluation of apoptosis, cell viability and cell cycle analysis by flow cytometry.

Application References

(PubMed link indicates BioLegend citation)
  1. Vermes I, et al.1995. J. Immunol. Methods 184:39.
  2. Darzynkiewicz Z, et al. 1992. Cytometry 13(8):795.
  3. Douglas RS, et al. 1995. J. Immunol. Methods 188:219.
  4. Sakimoto I, et al. 2006. Cancer Research 66:2287.PubMed
  5. Liu H, et al. 2012. Int J Biochem Cell Biol. 45:408. PubMed
  6. Juel HB, et al. 2013. PLoS One. 8:64619. PubMed
  7. Ren Q, et al. 2013. PLoS One. 8:74732. PubMed
  8. Zhao W, et al. 2013. Clin Immunol. 149:119. PubMed
  9. Beggs KM, et al. 2014. Toxicol Sci. 137:91. PubMed
  10. Ewald SE, et al. 2014. Infect Immun. 82:460. PubMed
  11. Tsou WI, et al. 2014. J Biol Chem. 289:25750. PubMed
  12. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
Product Citations
  1. Liu H, et al. 2012. Int J Biochem Cell Biol. 45:408. PubMed
  2. Ewald S, et al. 2014. Infect Immun . 82:460. PubMed
  3. Guo H, et al. 2016. Sci Rep. 6:37559. PubMed
  4. Smith A, et al. 2017. Sci Rep. 7:41872. PubMed
  5. Li W, et al. 2019. Aging (Albany NY). 0.99375. PubMed
  6. Glynn RA, et al. 2022. J Immunol. 208:371. PubMed
  7. Marques de Menezes EG, et al. 2022. MBio. 13:e0300521. PubMed
  8. Das Gupta D, et al. 2022. Cell Death Differ. 29:2163. PubMed
  9. Qin L, et al. 2022. Sci Adv. 8:eabn3774. PubMed
  10. Cheng Y, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:964. PubMed
  11. Choi UY, et al. 2022. Cell Rep. 40:111234. PubMed
  12. Park J, et al. 2022. Animals (Basel). 12: . PubMed
  13. Papakonstantinou A, et al. 2022. Int J Mol Sci. 24: . PubMed
  14. Blal K, et al. 2023. Cancers (Basel). 15: . PubMed
  15. Xiong E, et al. 2023. Front Immunol. 13:1083119. PubMed
  16. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  17. Bhardwaj M, et al. 2023. J Clin Invest. :. PubMed
  18. Hochrein SM, et al. 2022. Cell Metab. 34:516. PubMed
  19. Wenes M, et al. 2022. Cell Metab. 34:731. PubMed
  20. Evans SJ, et al. 2022. Toxicol In Vitro. 83:105415. PubMed
  21. Hagege A, et al. 2022. Cell Rep Med. 3:100659. PubMed
  22. Tintelnot J, et al. 2023. Nature. 615:168. PubMed
  23. Ohuchi K, et al. 2023. Biomed Rep. 18:28. PubMed
  24. Quintela M, et al. 2023. Clin Epigenetics. 15:63. PubMed
  25. Buckley MT, et al. 2023. Nat Aging. 3:121. PubMed
  26. Quintela M, et al. 2023. Br J Cancer. . PubMed
  27. Sohrabi N, et al. 2023. Iran J Public Health. 52:633. PubMed
  28. Papsdorf K, et al. 2023. Nat Cell Biol. 25:672. PubMed
  29. Schwartz PB, et al. 2023. PLoS Genet. 19:e1010770. PubMed
  30. Wyrobnik I, et al. 2023. Oncoimmunology. 12:2219164. PubMed
  31. Chan J, et al. 2017. Oncogene. 10.1038/onc.2017.319. PubMed
  32. Uroda T, et al. 2019. Mol Cell. 75:982. PubMed
  33. Lindqvist B, et al. 2022. PLoS Pathog. 18:e1010555. PubMed
  34. Neumann CKA, et al. 2020. Mol Metab. 34:136. PubMed
  35. Hamel Y, et al. 2021. Cell Rep Med. 2:100370. PubMed
  36. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  37. Leeth C, et al. 2021. Animals (Basel). 11:. PubMed
  38. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  39. McNeal AS, et al. 2021. Elife. 10:. PubMed
  40. Ren Q, et al. 2013. PLoS One. 8:74732. PubMed
  41. He Y, et al. 2020. Nat Commun. 11:1996. PubMed
  42. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  43. Yoshioka H, et al. 2021. Front Cell Dev Biol. 9:621045. PubMed
  44. Yang Y, et al. 2021. Metabolism. 123:154863. PubMed
  45. Sun X, et al. 2022. JCI Insight. 7: . PubMed
  46. Coray M, et al. 2022. Int J Mol Sci. 23:. PubMed
  47. Schrier S, et al. 2016. Sci Rep. 6:34942. PubMed
  48. O'Neill K, et al. 2016. Genes Dev. 30: 973-988. PubMed
  49. Sapanidou V, et al. 2015. Theriogenology. . PubMed
  50. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
  51. Zeng H, et al. 2018. Cancer Cell. 34:56:00. PubMed
  52. Lei W, et al. 2020. Sci Rep. 10:7004. PubMed
  53. Wang Y, et al. 2019. Cell. 179:1144. PubMed
  54. Zhang M, et al. 2017. Oncol Lett. 3.069444444. PubMed
  55. Zhang W, et al. 2021. J Clin Invest. 131:. PubMed
  56. Ambrosi TH, et al. 2021. Elife. 10: . PubMed
  57. Feng L, et al. 2016. J Cell Sci. 129: 2202 - 2212. PubMed
  58. Lange N, et al. 2016. PLoS One. 11: 0160843. PubMed
  59. Jordan PM, et al. 2020. Cell Rep. 33:108247. PubMed
  60. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  61. Liu L, et al. 2019. Cell Prolif. :e12718. PubMed
  62. Zou PA, et al. 2021. Oncol Lett. 22:648. PubMed
  63. Masuda T, et al. 2022. iScience. 25:104781. PubMed
  64. Reighard SD, et al. 2020. Cell Rep Med. :1. PubMed
  65. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  66. Xu B, et al. 2016. Leukemia. 10.1038/leu.2016.297. PubMed
  67. Liu Y, et al. 2017. Acta Biomater. 10.1016/j.actbio.2017.08.021. PubMed
  68. Domenis R, et al. 2017. PLoS One. 10.1371/journal.pone.0169932. PubMed
  69. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  70. Yang M, et al. 2021. Med Sci Monit. 27:e930083. PubMed
  71. Zhang X, et al. 2020. Eur J Med Chem. 112186:192. PubMed
  72. Mensen A, et al. 2015. Biol Blood Marrow Transplant. Available online 10 August 2015. PubMed
  73. Zhao W, et al. 2013. Clin Immunol. 149:119. PubMed
  74. Liu H, et al. 2020. Cell Death Dis. 0.767361111. PubMed
  75. Li L, et al. 2018. Oncol Lett. 4.184722222. PubMed
  76. Jung E, et al. 2017. J Neurosci. 37:6837. PubMed
  77. Basso-Ricci L, et al. 2017. Cytometry A. 10.1002/cyto.a.23148. PubMed
  78. Matsuda K, et al. 2021. Cell Rep Methods. 1:100122. PubMed
  79. Pang K, et al. 2022. Cell Death Dis. 13:169. PubMed
  80. Tang X, et al. 2021. Transl Cancer Res. 10:2120. PubMed
  81. Li Y, et al. 2016. Int J Lower Extrem Wounds. 10.1177/1534734616649485. PubMed
  82. Hu D, et al. 2020. Proc Natl Acad Sci U S A. 117:30639. PubMed
  83. Li Q, et al. 2020. Acta Biochim Biophys Sin (Shanghai). 52:1131. PubMed
  84. Moribe F, et al. 2021. PLoS One. 16:e0237554. PubMed
  85. Litzenburger UM, et al. 2017. Genome Biol. 18:15. PubMed
  86. Shanahan MT, et al. 2021. Am J Physiol Gastrointest Liver Physiol. 321:G668. PubMed
  87. Wang J, et al. 2022. J Clin Invest. :. PubMed
  88. Trudu M, et al. 2022. Front Oncol. 12:968208. PubMed
  89. L Chang, Y Li, D Kaplan 2016. Sci Rep. 6:36862. PubMed
  90. Perl AL, et al. 2019. J Biol Chem. 294:17043. PubMed
  91. Diaz Osterman CJ, et al. 2019. Elife. 8:e47327. PubMed
  92. Hosokawa T, et al. 2017. J Immunol. 10.4049/jimmunol.1700157. PubMed
  93. El-Hafeez A, et al. 2017. Cytotechnology. 10.1007/s10616-017-0124-1. PubMed
  94. Xue G, et al. 2021. Nat Biomed Eng. 5:1306. PubMed
  95. Lasrado N, et al. 2022. iScience. 25:103865. PubMed
  96. Tsou W, et al. 2014. J Biol Chem. 289:25750. PubMed
  97. Oubaha M, et al. 2016. Sci Transl Med. 8: 362ra144. PubMed
  98. Polk A, et al. 2016. Clin Cancer Res. 22(24):6118-6128. PubMed
  99. Harro CM, et al. 2020. J Clin Invest. . PubMed
  100. Imura Y, et al. 2020. JCI Insight. :5. PubMed
  101. Suzuki S, et al. 2021. STAR Protocols. 2:100683. PubMed
  102. Vickman R, et al. 2016. Mol Cancer Res. 14: 776 - 786. PubMed
  103. El-Hafeez A, et al. 2017. Cytotechnology. 10.1007/s10616-017-0116-1. PubMed
  104. Xie M, et al. 2017. BMC Cancer . 10.1186/s12885-017-3291-8. PubMed
  105. Pal P, et al. 2021. J Med Chem. 64:14230. PubMed
  106. Hedemann N, et al. 2021. Cancers (Basel). 13:. PubMed
  107. Xie B, et al. 2021. J Immunol. 206:1515. PubMed
  108. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  109. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  110. Huang K, et al. 2018. Biol Open. 7:bio029470. PubMed
  111. Wang H, et al. 2019. Nat Commun. 4.388194444. PubMed
  112. Matsubara T, et al. 2022. J Exp Med. 219:. PubMed
  113. Hughes K, et al. 2017. Open Bio. 10.1098/rsob.160155. PubMed
  114. Resch U, et al. 2016. MBio. 7: e00207-16. PubMed
  115. Bao W, et al. 2016. Sci Rep. 6:22579. PubMed
  116. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  117. Yang X, et al. 2017. J Control Release. 10.1016/j.jconrel.2017.07.014. PubMed
  118. Viereckl MJ, et al. 2022. Biomolecules. 12:. PubMed
  119. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  120. Beggs K, et al. 2014. Toxicol Sci. 137:91. PubMed
  121. Wang C, et al. 2017. Drug Deliv. 10.1080/10717544.2017.1293195. PubMed
  122. Nilsri N, et al. 2021. Sci Rep. 5255:11. PubMed
  123. Bjørnstad R, et al. 2019. Mol Cancer Ther. 1.14375. PubMed
  124. Ghura H, et al. 2021. Neoplasia. 23:837. PubMed
  125. He Y, et al. 2020. J Hematol Oncol. 0.607638889. PubMed
  126. Widodo N, et al. 2022. F1000Res. 11:169. PubMed
  127. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  128. Bensberg M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  129. Namas R, et al. 2016. Lupus Sci Med. 3: e000148. PubMed
  130. Chen Y, et al. 2016. J Biol Chem. 291: 13216 - 13228. PubMed
  131. Deng BB, et al. 2020. Cell Biol Int. 44:1890. PubMed
  132. Siddhartha V, et al. 2017. Artif Cells Nanomed Biotechnol . 10.1080/21691401.2017.1313267. PubMed
  133. Viseshakul N, et al. 2017. Parasitol Res. 10.1007/s00436-017-5589-5. PubMed
  134. Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
  135. Sakimoto I, et al. 2006. Cancer Res. 66:2287. PubMed
  136. Goel S, et al. 2021. Nat Commun. 12:5325. PubMed
  137. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  138. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  139. Mahmoudi M, et al. 2016. Sci Rep. 6:26960. PubMed
  140. Juel H, et al. 2013. PLoS One. 8:64619. PubMed
  141. Popa S, et al. 2020. Wellcome Open Res. 0.249305556. PubMed
  142. Vulin M, et al. 2022. Oncogene. :. PubMed

Antigen Details

Biology Area
Cell Biology, Cell Cycle/DNA Replication, Neuroscience
Gene ID
NA

Related FAQs

Why is washing not recommended after the addition 7-AAD or PI addition when assessing viability?

These dyes bind in equilibrium with DNA. Therefore, external dye concentration must be maintained during analysis and the dye should not be washed out.

Go To Top Version: 2    Revision Date: 10/08/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account